Anti‐CD5 extends the proliferative response of human CD5+ B cells activated with anti‐IgM and interleukin‐2
- 1 January 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (1), 57-62
- https://doi.org/10.1002/eji.1830260109
Abstract
The CD5 T cell glycoprotein which is expressed by a subset of B cells has been shown to be involved in T cell activation and proliferation. No similar studies, to date, have addressed the role of CD5 on the B cell subset. CD5+ and CD5− B cells were sorted and stimulated with anti-CD5 monoclonal antibody (mAb) in vitro. The activation and proliferative responses of these two populations, as measured by analysis of proliferation marker, did not differ following anti-μ and interleukin (IL)-2 stimulation. The addition of anti-CD5 did not change the responsiveness of such activated CD5+ B cells but resulted in a decrease in CD25 expression. Pre-activation of B cells with phorbol 12-myristate 13-acetate, which increased CD5 expression, failed to alter the proliferative response of CD5+ B cells to anti-μ and IL-2 with or without addition of anti-CD5 mAb. Anti-μ and IL-2 treatment of CD5+ cells resulted in optimal proliferation measured at day 3 which decreased by day 6. However, addition of anti-CD5 mAb at day 3 prevented this decline in proliferative response. This dose-dependent effect was observed only when the anti-CD5 mAb was presented to the B cells in cross-linked form. Co-stimulation of CD5 did not lower the threshold of antigen to which the B cells responded. Taken together, these data support a functional role for CD5 on B cells acting as an accessory signal, following their primary activation through the B cell receptor complex and highlight differences in the role of CD5 associated with the T cell receptor complex.Keywords
This publication has 31 references indexed in Scilit:
- Human CD5‐positive B Cells in lymphoid malignancy and connective tissue diseasesEuropean Journal of Clinical Investigation, 1993
- Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytesEuropean Journal of Immunology, 1992
- A new nomenclature for B cellsImmunology Today, 1991
- Immobilized anti‐CD5 together with prolonged activation of protein kinase C induce interleukin 2‐dependent T cell growth: evidence for signal transduction through CD5European Journal of Immunology, 1991
- Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5− B lymphocytesInternational Immunology, 1990
- Cell surface antigen CD5 is a marker for activated human B cellsEuropean Journal of Immunology, 1989
- Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis.The Journal of Experimental Medicine, 1988
- Rheumatoid Factor Secretion from Human Leu-1 + B CellsScience, 1987
- Human Lymphocytes Making Rheumatoid Factor and Antibody to ssDNA Belong to Leu-1 + B-Cell SubsetScience, 1987
- Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1Nature, 1986